ACM
LBPH

Altium Capital Management’s Longboard Pharmaceuticals, Inc. Common Stock LBPH Stock Holding History

Altium Capital Management’s Portfolio LBPH Stock Details LBPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-170,000
Closed -$3.67M – 88
2024
Q1 		$3.67M Buy
+170,000
New +$3.71M 1.45% 25

Other funds holding LBPH

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return

Altium Capital Management's LBPH Position: Q2 2024 in Review

Altium Capital Management sold out of Longboard Pharmaceuticals, Inc. Common Stock (LBPH) in Q2 2024, closing a stake of 170,000 shares — an estimated $3.67M sold.

Altium Capital Management first reported a position in LBPH in Q1 2024 and held it in 1 quarter. The position peaked at $3.67M in Q1 2024. 100 funds tracked by Wall St. Rank hold LBPH as of Q2 2024.

  • Altium Capital Management reported no remaining Longboard Pharmaceuticals, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Altium Capital Management sold 170,000 Longboard Pharmaceuticals, Inc. Common Stock shares in Q2 2024, an estimated $3.67M.
  • Altium Capital Management first reported a position in Longboard Pharmaceuticals, Inc. Common Stock in Q1 2024 and held it in 1 quarter.
  • Altium Capital Management's Longboard Pharmaceuticals, Inc. Common Stock position peaked at $3.67M in Q1 2024.
  • 100 funds tracked by Wall St. Rank held Longboard Pharmaceuticals, Inc. Common Stock as of Q2 2024.

Based on Altium Capital Management's 13F filing for Q2 2024, filed 15 Aug 2024.